TOWA PHARMACEUTICAL CO.,LTD.

4553

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-06FY2027 Q1

Revenue

2799.4100M JPY

YoY +6.8%

Operating Income

65.2100M JPY

YoY +25.2%

Net Income

82.7100M JPY

YoY -48.3%

EPS

112.4JPY

YoY +120.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

2737.1億円

2052.8億円

1368.5億円

684.3億円

Rev: 1656.2億円Op: 192.1億円NI: 159.1億円

Rev: 2088.6億円Op: 55.1億円NI: 22億円

Rev: 2279.3億円Op: 176.5億円NI: 161.7億円

Rev: 2595.9億円Op: 232.4億円NI: 189.9億円

Rev: 2737.1億円Op: 231億円NI: 52.5億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income25.7%

Revenue Progress713.800M

Revenue Forecast304000M

Net Income Progress55.300M

Net Income Forecast21500M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan